vinpocetine has been researched along with Hypertension in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grave, K; Hering, L; Hoch, H; Mergia, E; Potthoff, SA; Rump, LC; Sivritas, SH; Stegbauer, J; Thieme, M; Yang, G | 1 |
| Bakucheva, MV; Filatov, VF; Pizova, NV; Shadrichev, VA; Spirin, NN | 1 |
| Carneiro, FS; Giachini, FR; Lima, VV; Tostes, RC; Webb, RC | 1 |
| Chukanova, EI | 1 |
| Dzizinskiĭ, AA; Filatova, LN; Kuklin, SG; Protasov, KV; Shprakh, VV; Sinkevich, DA | 1 |
| Nevzorova, VA; Plotnikova, IV; Zakharchuk, NV | 1 |
| Buslo, EA; Galusha, AI; Shevchenko, VA; Zozulia, AA; Zozulia, IS | 1 |
| Burtsev, EM; Savkov, VS; Shprakh, VV | 1 |
| Vinichuk, SM | 1 |
| Atakhanova, MG; Panikarskiĭ, VG | 1 |
| Ishchenko, MM; Shkrobot, SI | 1 |
11 other study(ies) available for vinpocetine and Hypertension
| Article | Year |
|---|---|
Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Male; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphodiesterase 5 Inhibitors; Renal Artery; Renal Circulation; Sildenafil Citrate; Vasodilation; Vasodilator Agents; Vinca Alkaloids | 2017 |
[The use of cavinton in patients with lacunar stroke developed against the background of diabetes mellitus and arterial hypertension].
Topics: Administration, Oral; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Brain Infarction; Cerebrovascular Circulation; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vinca Alkaloids | 2007 |
Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1.
Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Blotting, Western; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Dose-Response Relationship, Drug; Hypertension; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Vasoconstriction; Vinca Alkaloids | 2011 |
[Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program "CALIPSO"].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cerebrovascular Disorders; Female; Humans; Hypertension; Male; Middle Aged; Russia; Treatment Outcome; Vinca Alkaloids | 2010 |
[Cavinton forte treatment of cerebral vascular insufficiency in patients with coronary heart disease and arterial hypertension].
Topics: Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Disorders; Coronary Disease; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Neuroprotective Agents; Treatment Outcome; Vinca Alkaloids | 2006 |
[The state of cerebral blood flow in hypertensive crises and possibilities of its correction].
Topics: Amlodipine; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cerebrovascular Circulation; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypertension; Middle Aged; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vinca Alkaloids | 2007 |
[The treatment of hypertension patients with neurological disorders].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Cerebrovascular Disorders; Diuretics; Drug Evaluation; Drug Therapy, Combination; Humans; Hypertension; Nervous System Diseases; Piracetam; Sodium Chloride Symporter Inhibitors; Vinca Alkaloids | 1990 |
[Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
Topics: Aged; Aging; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Drug Evaluation; Female; Humans; Hypertension; Intracranial Arteriosclerosis; Male; Middle Aged; Plethysmography, Impedance; Vasodilator Agents; Vinca Alkaloids | 1988 |
[Effect of corglycon and vasoactive agents on systemic and cerebral hemodynamics in cerebral infarct].
Topics: Aged; Cerebral Infarction; Cerebrovascular Circulation; Dipyridamole; Drug Evaluation; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Strophanthins; Vasodilator Agents; Vinca Alkaloids | 1987 |
[Complex treatment of patients with vegetovascular dystonia of the hypertensive type].
Topics: Adolescent; Adult; Autogenic Training; Combined Modality Therapy; Female; Humans; Hypertension; Male; Middle Aged; Neurocirculatory Asthenia; Vinca Alkaloids | 1986 |
[Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency].
Topics: Adult; Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Hemodynamics; Humans; Hypertension; Intracranial Arteriosclerosis; Male; Middle Aged; Plethysmography, Impedance; Rheology; Vinca Alkaloids | 1985 |